Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 96

1.

Saudi Oncology Society clinical management guidelines for prostate cancer.

Abusamra AJ, Bazarbashi S, Bahader Y, Kushi H, Rabah D, Al Bogami N, Al Ghamdi K, Al Ghamdi A, Balaraj K, Seyam R, Al Otaibi M, Al Saeed E.

Urol Ann. 2011 Mar;3 Suppl:S10-6. doi: 10.4103/0974-7796.78550. Erratum in: Urol Ann. 2011 May;3(2):61. Rabbah, Dany [corrected to Rabah, Danny].

2.

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.

Abusamra A, Murshid E, Kushi H, Alkhateeb S, Al-Mansour M, Saadeddin A, Rabah D, Bazarbashi S, Alotaibi M, Alghamdi A, Alghamdi K, Alsharm A, Ahmad I.

Urol Ann. 2016 Apr-Jun;8(2):123-30. doi: 10.4103/0974-7796.176872. Review.

3.

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder.

Alkhateeb S, Al-Mansour M, Alotaibi M, Saadeddin A, Abusamra A, Rabah D, Murshid E, Alsharm A, Ahmad I, Kushi H, Alghamdi A, Alghamdi K, Bazarbashi S.

Urol Ann. 2016 Apr-Jun;8(2):131-5. doi: 10.4103/0974-7796.176873. Review.

4.

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for renal cell carcinoma.

Alghamdi A, Alkhateeb S, Alghamdi K, Bazarbashi S, Murshid E, Alotaibi M, Abusamra A, Rabah D, Ahmad I, Al-Mansour M, Saadeddin A, Alsharm A.

Urol Ann. 2016 Apr-Jun;8(2):136-40. doi: 10.4103/0974-7796.179239. Review.

5.

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for testicular germ cell tumors.

Alotaibi M, Saadeddin A, Bazarbashi S, Alkhateeb S, Alghamdi A, Alghamdi K, Murshid E, Abusamra A, Rabah D, Ahmad I, Al-Mansour M, Alsharm A.

Urol Ann. 2016 Apr-Jun;8(2):141-5. doi: 10.4103/0974-7796.179240. Review.

6.

Saudi oncology society and Saudi urology association combined clinical management guidelines for renal cell carcinoma.

Bazarbashi S, Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Almansour M, Murshid E, Alsharm A, Alolayan A, Ahmad I, Alghamdi K, Alghamdi A.

Urol Ann. 2014 Oct;6(4):286-9. doi: 10.4103/0974-7796.140974.

7.

Saudi oncology society and Saudi urology association combined clinical management guidelines for testicular germ cell tumors.

Alotaibi M, Bazarbashi S, Alkhateeb S, Abusamra A, Rabah D, Almansour M, Murshid E, Alsharm A, Ahmad I, Alghamdi K, Saadeddin A, Alghamdi A.

Urol Ann. 2014 Oct;6(4):290-5. doi: 10.4103/0974-7796.140978.

8.

Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer.

Al-Mansour M, Saadeddin A, Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Murshid E, Alsharm A, Ahmad I, Alghamdi K, Bazarbashi S.

Urol Ann. 2014 Oct;6(4):273-7. doi: 10.4103/0974-7796.140941.

9.

Verrucous carcinoma presenting as giant plantar horns.

AlShahwan MA, AlGhamdi KM, AlSaif FM.

Dermatol Surg. 2007 Apr;33(4):510-2. No abstract available.

PMID:
17430391
10.

Treatment of generalized vitiligo with anti-TNF-α Agents.

Alghamdi KM, Khurrum H, Taieb A, Ezzedine K.

J Drugs Dermatol. 2012 Apr;11(4):534-9.

PMID:
22453596
11.

Worsening of vitiligo and onset of new psoriasiform dermatitis following treatment with infliximab.

Alghamdi KM, Khurrum H, Rikabi A.

J Cutan Med Surg. 2011 Sep-Oct;15(5):280-4.

PMID:
21962188
12.

Methotrexate for the treatment of generalized vitiligo.

Alghamdi K, Khurrum H.

Saudi Pharm J. 2013 Oct;21(4):423-4. doi: 10.1016/j.jsps.2012.12.003. No abstract available.

13.

Pilot trial evaluating the treatment of focal vitiligo with intralesional honeybee venom injection.

AlGhamdi KM, Khurrum H.

J Cutan Med Surg. 2012 Nov-Dec;16(6):385-6. No abstract available.

PMID:
23149190
14.

Successful treatment of atrophic facial leishmaniasis scars by co2 fractional laser.

AlGhamdi K, Khurrum H.

J Cutan Med Surg. 2014 Nov;18(6):379-84.

PMID:
25348758
15.

Professional use of the internet among Saudi Arabian dermatologists: a cross-sectional survey.

Alghamdi KM.

BMC Dermatol. 2009 Oct 16;9:10. doi: 10.1186/1471-5945-9-10.

16.

Penile juvenile xanthogranuloma and neurofibromatosis type-1: risk association with juvenile myelomonocytic leukaemia?

AlGhamdi KM, Al Suwaidan SN.

East Mediterr Health J. 2010 Apr;16(4):451-4. No abstract available.

PMID:
20795434
17.

Failure of alefacept in the treatment of vitiligo.

Bin Dayel S, AlGhamdi K.

J Drugs Dermatol. 2013 Feb;12(2):159-61.

PMID:
23377387
18.

Skin care: Historical and contemporary views.

AlGhamdi KM, AlHomoudi FA, Khurram H.

Saudi Pharm J. 2014 Jul;22(3):171-8. doi: 10.1016/j.jsps.2013.02.005. Epub 2013 Mar 14. Review.

19.

Assessment methods for the evaluation of vitiligo.

Alghamdi KM, Kumar A, Taïeb A, Ezzedine K.

J Eur Acad Dermatol Venereol. 2012 Dec;26(12):1463-71. doi: 10.1111/j.1468-3083.2012.04505.x. Epub 2012 Mar 15. Review.

PMID:
22416879
20.

Depigmentation therapies for normal skin in vitiligo universalis.

AlGhamdi KM, Kumar A.

J Eur Acad Dermatol Venereol. 2011 Jul;25(7):749-57. doi: 10.1111/j.1468-3083.2010.03876.x. Epub 2010 Nov 4. Review.

PMID:
21054565

Supplemental Content

Support Center